2025
Intranasal administration of octadeca-neuropeptide analog protects dopaminergic neurons from MPTP-induced neurotoxicity in a mouse model of Parkinson’s diseaseNeuroscience, Neuropeptides and Animal Physiology
Active, last published 2026
In neurotransmitter receptor influence on behavior
Zeineb
Fridhi
“Research focused on Neurotransmitter Receptor Influence on Behavior and adjacent fields.”
Tunis El Manar UniversityTunisia
Claim Your Profile0
H-index
0
Citations
Zeineb has not officially claimed their profile. If you are Zeineb, claim it free.
Claim Your Profile01 · About the work
What I study
eineb Fridhi is a researcher working on Neurotransmitter Receptor Influence on Behavior. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Zeineb's work has been cited 0 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
05 · Research focus
Topics
Neurotransmitter Receptor Influence on Behavior×1Parkinson's Disease Mechanisms and Treatments×1Epigenetics and DNA Methylation×1Nerve injury and regeneration×1Neuropeptides and Animal Physiology×1
06 · Where I am
Affiliations
CurrentlyTunis El Manar University, Tunisia
Research themes (UN SDGs)
07 · Selected work
Recent publications
2025
Neuroprotective Effects of Intranasally Administered Octadecaneuropeptide Analog in a Mouse Model of MPTP-Induced Parkinson's DiseaseJournal of Visualized Experiments, Adenosine and Purinergic Signaling
2026Open access
Regional and temporal dynamics of DNA methylation and epigenetic gene regulation in response to binge-like alcohol exposure in the adolescent mouse brainFrontiers in Molecular Neuroscience, Prenatal Substance Exposure Effects
Are you Zeineb?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required